Evidence map›Paper›PMID 40717390›Full record

ArticleAdvanced healthcare materials2025

Predicting Mechanosensitive T Cell Expansion from Cell Spreading.

Xin Wang, Ruiting Xu, Shiqi Hu, Daizong Sun, Jia Guo, Nicole Lamanna, Lance C Kam

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Leveraging Microphysiological Systems to Facilitate Neutrophil-Based Cancer Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xin WangDepartment of Biomedical Engineering, Columbia University, New York, 10027, USA.
Ruiting XuDepartment of Biomedical Engineering, Columbia University, New York, 10027, USA.
Shiqi HuDepartment of Biomedical Engineering, Columbia University, New York, 10027, USA.
Daizong SunDepartment of Biomedical Engineering, Columbia University, New York, 10027, USA.
Jia GuoDepartment of Psychiatry, Department of Biomedical Engineering, Columbia University, New York, 10027, USA.
Nicole LamannaDepartment of Medicine, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, 10032, USA.
Lance C KamDepartment of Biomedical Engineering, Department of Medicine, Columbia University, New York, 10027, USA.ORCID 0000-0001-6812-4956

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
Synaptic Control of Cytotoxic T cell FunctionR01AI087644 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI HUSE, MORGAN A · 2010 to 2025
$7.3M
Advanced Rigidity-based Material for Enhanced ImmunotherapyR01AI110593 · NIAID · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI KAM, LANCE C · 2015 to 2018
$1.6M
Spatial coordination of CD28 and TCR signalingR01AI088377 · NIAID · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI KAM, LANCE C · 2010 to 2013
$1.3M
Multidisciplinary Training in Gastrointestinal CancersT32CA285274 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Julian Abrams, Anil K Rustgi · 2024 to 2026
$897k
Microscale System for Functional T Cell TranscriptomicsR21AI154867 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KAM, LANCE C · 2021 to 2022
$430k
National Science Foundation CMMI 1562905NCI NIH HHS P30 CA013696NCI NIH HHS T32 CA285274NIAID NIH HHS R01 AI087644NIAID NIH HHS R01 AI088377NIAID NIH HHS R01 AI110593NIAID NIH HHS R21 AI154867NIH HHS P30CA013696NIH HHS R01AI087644NIH HHS R01AI088377
6 · The paper itself

Abstract

Variability in T cell performance presents a major challenge to adoptive cellular immunotherapy (ACT). This includes expansion of a small starting population into therapeutically effective numbers, which can fail due to differences between individuals and disease states. Intriguingly, modulating the mechanical stiffness of materials used to activate T cells can rescue subsequent expansion. However, the magnitude of this effect and the optimal stiffnesses differ between individuals, complicating the use of mechanosensing to improve cell production. The ability to predict this long-term, substrate-dependent expansion from a short-term assay would accelerate the deployment of immunotherapy. Here, it is demonstrated that short-term cell spreading predicts subsequent, mechanosensitive expansion. As an initial task, cell spreading is used to identify whether a sample of cells came from a healthy donor or a Chronic Lymphocytic Leukemia (CLL) patient. Notably, a deep learning (DL) model outperforms morphometric approaches to this classification task. This system also successfully predicts the long-term expansion potential of cells as a function of both source and mechanical stiffness of the activating substrate. By predicting long-term T cell function from small, diagnostic samples, this approach will improve the reliability and efficacy of cell production and immunotherapy.

Indexed as

Mechanotransduction, CellularT-LymphocytesCell ProliferationDeep LearningHumansImmunotherapy, AdoptiveLeukemia, Lymphocytic, Chronic, B-Cellbiomaterialscellular immunotherapymachine learningmechanosensingT cells

Identifiers

PMID40717390
PMCPMC12367345

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.